Your browser doesn't support javascript.
loading
miRNAs in pancreatic cancer progression and metastasis.
Mok, Ellie T Y; Chitty, Jessica L; Cox, Thomas R.
Afiliación
  • Mok ETY; Matrix & Metastasis Lab, Cancer Ecosystems Program, The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Chitty JL; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, UNSW Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
  • Cox TR; Matrix & Metastasis Lab, Cancer Ecosystems Program, The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia. j.chitty@garvan.org.au.
Clin Exp Metastasis ; 41(3): 163-186, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38240887
ABSTRACT
Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells. Dysregulation of miRNA expression and function has been linked to a variety of diseases including cancer. They play a complex role in cancers, having both tumour suppressor and promoter properties. In addition, a single miRNA can be involved in regulating several mRNAs or many miRNAs can regulate a single mRNA, therefore assessing these roles is essential to a better understanding in cancer initiation and development. Pancreatic cancer is a leading cause of cancer death worldwide, in part due to the lack of diagnostic tools and limited treatment options. The most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC), is characterised by major genetic mutations that drive cancer initiation and progression. The regulation or interaction of miRNAs with these cancer driving mutations suggests a strong link between the two. Understanding this link between miRNA and PDAC progression may give rise to novel treatments or diagnostic tools. This review summarises the role of miRNAs in PDAC, the downstream signalling pathways that they play a role in, how these are being used and studied as therapeutic targets as well as prognostic/diagnostic tools to improve the clinical outcome of PDAC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Regulación Neoplásica de la Expresión Génica / Progresión de la Enfermedad / Carcinoma Ductal Pancreático / MicroARNs Límite: Animals / Humans Idioma: En Revista: Clin Exp Metastasis Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Regulación Neoplásica de la Expresión Génica / Progresión de la Enfermedad / Carcinoma Ductal Pancreático / MicroARNs Límite: Animals / Humans Idioma: En Revista: Clin Exp Metastasis Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Países Bajos